Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 69.76%8.71M | 57.71%5.13M | -46.43%3.25M | -78.60%6.07M | 2,357.02%28.38M | -20.88%1.15M | 1.46M |
| Cost of revenue | 67.91%8.31M | 36.04%4.95M | -0.82%3.64M | -82.55%3.67M | 21.03M | ||
| Gross profit | 120.92%394.52K | 146.15%178.58K | -116.11%-387K | -67.31%2.4M | 7.35M | ||
| Operating expense | -115.49%-584.14K | -49.57%3.77M | 147.68%7.48M | 14.17%3.02M | 2.64M | ||
| Selling and administrative expenses | -19.58%3.16M | -48.18%3.93M | 73.70%7.58M | 50.01%4.36M | --2.91M | ---- | ---- |
| -General and administrative expense | -19.58%3.16M | -48.18%3.93M | 73.70%7.58M | 50.01%4.36M | --2.91M | ---- | ---- |
| Total other operating income | 2,290.56%3.74M | 53.65%156.58K | -92.42%101.9K | 408.34%1.34M | --264.51K | ---- | ---- |
| Operating profit | 127.24%978.66K | 54.32%-3.59M | -1,172.72%-7.87M | -113.14%-618.05K | 307.16%4.7M | -20.88%1.15M | 1.46M |
| Net non-operating interest income (expenses) | 95.36%-5.53K | 30.34%-119.36K | -605.91%-171.34K | -82.63%-24.27K | -13.29K | ||
| Non-operating interest expense | -95.36%5.53K | -30.34%119.36K | 605.91%171.34K | 82.63%24.27K | --13.29K | ---- | ---- |
| Net investment income | |||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | |||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | |||||||
| Income from associates and other participating interests | |||||||
| Special income (charges) | |||||||
| Other non-operating income (expenses) | |||||||
| Income before tax | 126.21%973.13K | 53.81%-3.71M | -1,151.30%-8.04M | -113.70%-642.32K | 306.01%4.69M | -20.88%1.15M | 1.46M |
| Income tax | -109.26%-2.23K | 117.42%24.12K | 92.61%-138.44K | -189.57%-1.87M | 2.09M | ||
| Net income | 126.10%975.36K | 52.70%-3.74M | -741.90%-7.9M | -52.64%1.23M | 124.98%2.6M | -20.88%1.15M | 1.46M |
| Net income continuous operations | 126.10%975.36K | 52.70%-3.74M | -741.90%-7.9M | -52.64%1.23M | 124.98%2.6M | -20.88%1.15M | --1.46M |
| Noncontrolling interests | |||||||
| Net income attributable to the company | 126.10%975.36K | 52.70%-3.74M | -741.90%-7.9M | -52.64%1.23M | 124.98%2.6M | -20.88%1.15M | 1.46M |
| Preferred stock dividends | |||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 126.10%975.36K | 52.70%-3.74M | -741.90%-7.9M | -52.64%1.23M | 124.98%2.6M | -20.88%1.15M | 1.46M |
| Gross dividend payment | |||||||
| Basic earnings per share | 125.94%0.0097 | 52.66%-0.0374 | -742.28%-0.079 | -52.66%0.0123 | 124.98%0.026 | -20.88%0.0116 | 0.0146 |
| Diluted earnings per share | 125.94%0.0097 | 52.66%-0.0374 | -742.28%-0.079 | -52.66%0.0123 | 124.98%0.026 | -20.88%0.0116 | 0.0146 |
| Dividend per share | 0 | 0 | 0 | 0.0063 | |||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.